Cargando…

Possible association of keratoconus progression with gender-affirming hormone therapy: A case report

PURPOSE: To present a case of keratoconus progression following gender-affirming hormone therapy. OBSERVATIONS: A 28-year-old male-to-female transgender patient with potential past ocular history of subclinical keratoconus presented with subacute worsening myopia of both eyes (OU), 4 months after in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deitel, Carli M., Chen, Kevin H., Uber, Ian C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149176/ https://www.ncbi.nlm.nih.gov/pubmed/37131527 http://dx.doi.org/10.1016/j.ajoc.2023.101850

Ejemplares similares

Localized Rhabdomyolysis Associated With Testosterone Enanthate for Gender-Affirming Hormonal Therapy
por: Reddy, Rashmi, et al.
Publicado: (2022)

Keratoconus progression associated with hormone replacement therapy
por: Coco, Giulia, et al.
Publicado: (2019)

Gender-affirming hormone therapy in cystic fibrosis – A case of new Pseudomonas infection
por: Shaffer, L., et al.
Publicado: (2021)

Frequency and Characteristics of Postoperative Neuropathy in Individuals on Gender-Affirming Hormone Therapy Undergoing Gender Affirmation Surgery: A Retrospective Cohort Study
por: Togioka, Brandon M, et al.
Publicado: (2023)

Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018)

Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022)

100. Patterns of Perioperative Hormone Therapy for Gender-affirming Surgery
por: Hung, Ya-Ching, et al.
Publicado: (2023)

Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy
por: Jackson Cullison, Stephanie R., et al.
Publicado: (2020)

Breast cancer in a transgender woman undergoing gender-affirming exogenous hormone therapy
por: Villalba, Michael D., et al.
Publicado: (2023)

Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)

Effects of Gender-Affirming Hormone Therapy on Progression Along the HIV Care Continuum in Transgender Women
por: Summers, Nathan A, et al.
Publicado: (2021)

The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
por: Schutte, Moya H., et al.
Publicado: (2022)

The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy
por: Yau, Mabel, et al.
Publicado: (2023)

Gender-Affirming Hormone Therapy: Physical and Sociopsychological Effects, Impact and Satisfaction
por: Santos, Rafael B, et al.
Publicado: (2023)

Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
por: Konadu, Melisande E., et al.
Publicado: (2023)

A Review of Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults in South Korea
por: OH, Jeong-Won, et al.
Publicado: (2022)

Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults
por: Connelly, Paul J., et al.
Publicado: (2019)

Gender-affirming hormone therapy induces specific DNA methylation changes in blood
por: Shepherd, Rebecca, et al.
Publicado: (2022)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

ODP148 GENDER AFFIRMING HORMONE THERAPY AND SPONTANEOUS CORONARY ARTERY DISSECTION
por: Yogeswaran, Vidhushei, et al.
Publicado: (2022)

Gender affirming hormone therapy dosing behaviors among transgender and nonbinary adults
por: Restar, Arjee, et al.
Publicado: (2022)

Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women
por: de Nie, Iris, et al.
Publicado: (2023)

SAT413 Feminising Gender Affirming Hormone Therapy Prolongs QTc Interval
por: Angus, Lachlan, et al.
Publicado: (2023)

Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy
por: Sánchez-Toscano, Esteban, et al.
Publicado: (2023)

Transitioning Bodies. The Case of Self-Prescribing Sexual Hormones in Gender Affirmation in Individuals Attending Psychiatric Services
por: Metastasio, Antonio, et al.
Publicado: (2018)

Abstract 65: Effects of gender affirming hormone therapy on metabolic health and body composition in gender dysphoria
por: Kiran, Baratam Hari, et al.
Publicado: (2022)

Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults
por: Iwamoto, Sean J., et al.
Publicado: (2023)

Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment
por: Masumori, Naoya, et al.
Publicado: (2023)

Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database
por: Yelehe, Melissa, et al.
Publicado: (2022)

Suicidal attempts and non-suicidal self-injury during gender affirming hormone therapy (GAHT) – a case report
por: Puzio, D., et al.
Publicado: (2022)

An Effective Gender-Affirming Care and Hormone Prescribing Standardized Patient Case for Residents
por: Hersh, Ben J., et al.
Publicado: (2022)

Factors Associated with Gender-Affirming Surgery and Age of Hormone Therapy Initiation Among Transgender Adults
por: Beckwith, Noor, et al.
Publicado: (2017)

The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review
por: Chan Swe, Nyein, et al.
Publicado: (2022)

An Approach to Nonsuppressed Testosterone in Transgender Women Receiving Gender-Affirming Feminizing Hormonal Therapy
por: Maheshwari, Arvind, et al.
Publicado: (2021)

Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review
por: Connelly, Paul J., et al.
Publicado: (2021)

SAT412 Effects Of Gender-Affirming Hormone Therapy On The Connectivity Of Intrinsic Brain Networks
por: Pedreira, Clarissa C, et al.
Publicado: (2023)

OR05-4 Case Series of Transmasculine Adolescents Who Developed Polycythemia on Gender Affirming Hormone Therapy
por: Latysheva, Natalya
Publicado: (2022)

Assessing Patient Goals for Gender-Affirming Hormone Therapy: A Standardized Patient Case for Medical Students
por: Spigner, Sabina T., et al.
Publicado: (2023)

OR31-03 Testosterone Gender-affirming Hormonal Therapy Is Associated With Decreased Cerebral Blood Flow In Transgender Teens
por: Cote, Samantha, et al.
Publicado: (2023)

Incorporating Transition-Affirming Language into Anatomical Pathology Reporting for Gender Affirmation Surgery
por: Ahmad, Tehmina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p8shbmstoqbiue0q42kj88ab06